DHODH inhibitor

Kiora Pharmaceuticals Advances Key Clinical Programs

ENCINITAS, Calif., August 7, 2026 Kiora Pharmaceuticals reported second quarter 2026 financial results while highlighting continued progress across its...

By cGxPwire Editor
August 8, 2026

Bio-Pharma

Kiora Secures New U.S. Patent Expanding KIO-104 Formulation Options

Encinitas, California — December 1, 2025 — Kiora Pharmaceuticals has been granted a new U.S. patent (US-12,472,263) covering additional...

By cGxPwire Editor
December 2, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

DHODH inhibitor

Kiora Pharmaceuticals Advances Key Clinical Programs

Kiora Secures New U.S. Patent Expanding KIO-104 Formulation Options